Is ensidipine expected to be included in medical insurance in 2024?
Regarding the issue of whether ensidipine is included in medical insurance, according to the currently available information, encidipine has not yet been included in the scope of medical insurance payment.
The medical insurance catalog is an important basis for determining which drugs can enjoy medical insurance reimbursement. According to publicly released information, ensidipine does not appear on the current Medicare list. This means that in most cases, patients need to pay for ensidipine at their own expense and cannot enjoy preferential reimbursement by medical insurance.
It should be noted that medical insurance policies are not static, but will be dynamically adjusted based on clinical needs, drug efficacy, economic costs and other factors. Therefore, whether ensidipine will be included in medical insurance in the future requires attention to the latest developments in medical insurance policies.
Although ensidipine is not yet covered by medical insurance, it has important therapeutic significance in the treatment of patients with acute myeloid leukemia (AML) who carry isocitrate dehydrogenase-2 (IDH2) mutations. This targeted therapy drug can target specific gene mutations, providing a new treatment option for AML patients.
It is important for patients who require ensidipine to understand the reimbursement status of the drug. Patients and doctors should pay attention to the latest developments in medical insurance policies to learn in a timely manner whether ensidipine may be included in medical insurance. At the same time, patients can also consult their local medical insurance department or medical institution to obtain more detailed information and suggestions.
Given the high price of ensidipine, the financial burden may be significant for patients requiring this drug. Therefore, patients and physicians can explore other financial assistance programs or philanthropic programs to alleviate patients' financial stress.
References:
https://go.drugbank.com/drugs/DB13874
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)